Positive data from the phase III LIBERTY-CUPID Study C evaluating the investigational use of Dupixent (dupilumab) in biologic-naive patients with uncontrolled chronic spontaneous urticaria (CSU) who receive background… read more.
Abbott announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options. The TEAM-HF trial, which… read more.
After only one to three days of a whiplash injury, scientists can predict which patients will develop chronic pain based on the extent of cross ‘talk’ between two… read more.
Rehab Elhiny (University College, Cork, Ireland and Minia University, Egypt) was awarded the best poster prize for her poster entitled ‘Goal attainment, medication adherence and guideline adherence in… read more.
Therapeutic advances in lung cancer Molecular testing before the start of treatment is good clinical practice (GCP) and confers considerable benefits in survival, according to Professor Joanna Chorostowska-Wynimko… read more.
Hussain S. Lalani, MD, MPH, MSc, of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, is the lead author of a paper published in JAMA,… read more.
Bristol Myers Squibb announced that new clinical and health economics and outcomes research data (HEOR) from its neuropsychiatry portfolio evaluating obenfy (xanomeline and trospium chloride) in schizophrenia in… read more.
Plus Therapeutics a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, will have multiple opportunities to present data at the… read more.
As athletes prepare to dive into Hawaiian waters for the first part of the IRONMAN World Championship on Oct. 26, they may want to pay a little extra… read more.
About 10% of Americans believe they are allergic to penicillin, and approximately 90% of those patients are not actually allergic. As a result, those with the penicillin allergy… read more.
Bayer and its collaboration partner Regeneron presented results from the open-label extension study of the clinical trial PHOTON in patients with diabetic macular edema (DME) at three years,… read more.
Eye care specialists could see artificial intelligence help in diagnosing infectious keratitis (IK), a leading cause of corneal blindness worldwide, as a new study finds that deep learning… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
